Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational studyFederica Martella, Eloise Beggiato, Marco Cerrano et al.|Annals of Hematology|2022Cited by 38
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic FactorsEleonora Boscaro, Marco Cerrano, Irene Urbino et al.|Cancers|2023Cited by 35
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021Irene Urbino, Marco Cerrano, Semra Aydin et al.|Cancers|2021Cited by 21
<scp>Validation of National Early Warning Score and Quick Sequential</scp> (<scp>sepsis‐related</scp>) <scp>Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy</scp>Chiara Frairia, Ernesta Audisio, Barbara Nicolino et al.|European Journal Of Haematology|2023Cited by 12
Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center studyIrene Urbino, Ernesta Audisio, Chiara Frairia et al.|Mediterranean Journal of Hematology and Infectious Diseases|2023Cited by 11